Who
In numbers
- Trades disclosed
- 79
- Buys
- 7
- Sells
- 8
- Bought
- $295K
- Sold
- $395K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Jun 2020
- Last trade
- 6 Sep 2026
- Last filed
- 9 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Sep 2026filed 9 Sep 2026 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code F | $1,787209 at $8.55 | filing |
| 6 Sep 2026filed 9 Sep 2026 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code F | $1,787209 at $8.55 | filing |
| 6 Jun 2026filed 9 Jun 2026 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code F | $1,329198 at $6.71 | filing |
| 6 Jun 2026filed 9 Jun 2026 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code F | $1,329198 at $6.71 | filing |
| 14 May 2026filed 19 May 2026 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Bought | $20K2,800 at $7.09 | filing |
| 14 May 2026filed 19 May 2026 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Bought | $20K2,800 at $7.09 | filing |
| 14 May 2026filed 18 May 2026 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Bought | $20K2,800 at $7.09 | filing |
| 14 May 2026filed 18 May 2026 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Bought | $20K2,800 at $7.09 | filing |
| 6 Mar 2026filed 10 Mar 2026 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code F | $1,895277 at $6.84 | filing |
| 6 Mar 2026filed 10 Mar 2026 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code F | $1,895277 at $6.84 | filing |
| 3 Feb 2026filed 5 Feb 2026 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 6 Dec 2025filed 9 Dec 2025 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code F | $2,181259 at $8.42 | filing |
| 17 Nov 2025filed 17 Nov 2025 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Bought | $25K2,700 at $9.10 | filing |
| 13 Nov 2025filed 17 Nov 2025 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Bought | $9,1801,000 at $9.18 | filing |
| 6 Sep 2025filed 9 Sep 2025 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code F | $3,001248 at $12.10 | filing |
| 6 Jun 2025filed 9 Sep 2025 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code F | $1,926246 at $7.83 | filing |
| 24 Mar 2025filed 25 Mar 2025 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Bought | $51K145,000 at $0.35 | filing |
| 6 Mar 2025filed 7 Mar 2025 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code F | $8,59522,038 at $0.39 | filing |
| 6 Mar 2025filed 7 Mar 2025 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code A | —781 at $0.00 | filing |
News
Kyntra Bio (KYNB): Can Its New Strategy And Pipeline Revive Investor Interest?KYNB · rttnews.com · 19 Oct 2026Kyntra Bio Inc (KYNB) – What Are Brokerages Saying About This Stock?KYNB · dailypolitical.com · 14 Oct 2026Prothena (NASDAQ:PRTA) vs. Kyntra Bio (NASDAQ:KYNB) Financial ReviewKYNB · dailypolitical.com · 12 Oct 2026
0 headlines in the last 90 days name Thane Wettig; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.